Clinical and serological responses investigated in rhesus and cynomolgus monkeys infected with either Bunyamwera or Germiston viruses were generally minimal or absent. A febrile reaction occurred in one of eight monkeys, and another monkey died unexplainably among those given Bunyamwera virus. All monkeys infected with Germiston virus by subcutaneous, intravenous, or intracerebral routes developed fevers, and all infections were relatively consistent in time of onset, duration, and level of viremia. Rhesus monkeys were also susceptible to infection by exposure to aerosolized Germiston virus, although viremias were irregular in these animals, and no fevers were detected. Serological responses to infections by Bunyamwera and Germiston viruses (hemagglutination inhibition, complement fixation, and neutralization tests) provided more reliable indications of infection than clinical response.
Studies of the Bunyamwera group of arboviruses have indicated that a serological relationship between Bunyamwera and Germiston viruses exists (2, 10) and that immunization of mice with one virus elicits protection against subsequent lethal challenges with the other virus (1; W. P. Allen and A. Schwartz, unpublished data). On the other hand, no cross-protection between these viruses was evident in a man who possessed neutralizing antibodies to Bunyamwera virus and then contracted a laboratory infection with Germiston virus (9) . In pursuit of a better understanding of cross-protection between these viruses, an experimental primate host was sought in which pathogenesis and immunological responses could be studied. The literature revealed that rhesus and vervet monkeys are susceptible to one or both of these viruses (12, 14) . Rhesus and cynomolgus monkeys were chosen for the present studies which describe observations on the infectivity, pathogenesis, and serological responses.
MATERIALS AND METHODS
Virus strains. Bunyamwera and Germiston viruses were obtained from the American Type Culture Collection. Bunyamwera virus had undergone 39 suckling mouse brain passages prior to its use in these experiments, and Germiston virus strain SAAR 1050 was in the 10th suckling mouse brain passage. Seeds were prepared as 10% suspensions of infected suckling 1 mouse brains. Concentrations of virus were determined by titration and inoculation of weanling mice. The Spearman-Karber method (4) was used for estimating median lethal doses (LD5o) which were expressed as decimal exponent (Dex) values (6) .
Monkeys. Rhesus (Macaca mulatta) and cynomolgus (M. irus) monkeys weighing 3.5 to 6 lb (1.6 to 2.7 kg) served as experimental hosts for these studies. Only those animals were used in which no neutralizing antibody against either virus could be detected. Monkeys infected by other than the aerosol route were conditioned to restraint in primate chairs for 2 days before inoculation of virus. Rectal thermocouples were attached to a recording potentiometer that automatically recorded internal temperatures at 40-min intervals. Monkeys exposed to aerosolized virus were held individually in ventilated cages to preclude transmission of infectious virus from monkey to monkey by contact or aerosol.
Assay for viremia. Periodically, following exposure of the monkeys to virus, blood samples were drawn into syringes wet with heparin and immediately diluted 1 :10 in broth. Virus concentrations were determined by inoculating 0.03 ml of each decimal dilution into 10-to 14-g mice by the intracerebral (ic) route and calculating LD,5 values from the observed deaths.
Method of exposing monkeys to infectious virus. Monkeys were inoculated with virus intravenously (iv) by the saphenous or cephalic veins, subcutaneously (sc) in the posterior lumbar region, or ic. Those inoculated by the ic route were anesthetized, and virus was injected through a drilled hole in the calvarium into the substance of the cerebrum. Exposure of the monkeys to aerosols of virus was accomplished without sedation in a Henderson apparatus that was modified to permit whole-body exposure (11) . Dynamic aerosols were generated for 3 min with a Colli-762 son atomizer, and the cloud was sampled by all-glass impingers. The virus concentrations in the atomizer and impinger samples were determined by assays in mice, and from these data inhaled doses of the aerosolized virus in terms of MICLD50 were calculated by using Guyton's equation (5) Virus was detected in the blood immediately after iv inoculation and increased to maximal titers 12 to 24 hr later (Table 3 ). In monkeys receiving virus by the sc route, viremias were first detected in the 12-hr samples; titers in these animals also were maximal between the 12th and 24th hr. Viremias persisted until the 3rd and 4th postinoculation day and were undetectable thereafter. Viremias in cynomolgus monkeys appeared slightly higher in titer than those in rhesus monkeys and persisted longer after iv inoculation than after sc inoculation.
Hematocrit, total, and differential white blood cell counts, and sedimentation rates were performed on all the monkeys daily throughout the 10-day observation period. Only hematocrit values varied from accepted normal values. Seven days after inoculation, hematocrit values dropped to an average level of 32.8%, which represented a decrease of 6 to 10% from preinoculation values. However, hematocrit values also decreased in two uninoculated monkeys tested simultaneously, and it is probable that the observed changes were caused by the daily bleedings rather than by the infection with Germiston virus. All monkeys infected with Germiston virus developed LNI of greater than 4.0 by the 21st day.
Three additional rhesus monkeys were tested for their responses to infection by the ic route. were substantially lower than those of monkeys infected with larger doses by iv or sc routes. Except for the expected pawing at the head, the depression that occurred within 24 hr after anesthesia, and invasion of the calvaria, no signs attributable to encephalitis were detected. One monkey had diarrhea from day 5 to 7 but responded to routine treatment. Twenty-one days after inoculation each of the three animals had LNI of greater than 6.0. The possibility of aerogenic transmission in man (9) prompted us to investigate the infectivity of aerosolized Germiston virus for monkeys. Nineteen rhesus monkeys were exposed to aerosolized virus at estimated inhaled doses ranging from 2 to 16,000 MICLD50. Three monkeys that inhaled an estimated 2 MICLD50 and two each that inhaled approximately 16 and 160 MICLD50 failed to become infected by the criteria of sero- Table 4 , and the serological responses are summarized in Table 5 .
Frank clinical signs were not detected. Rectal temperatures of the infected and noninfected monkeys, measured daily without the aid of thermocouples, fluctuated between 99.6 and 104 F ( 37.5 and 40 C) throughout the 10-day observation period because of the excitement caused by handling.
Although other routes of inoculation produced rather consistent patterns of viremia, infection by the respiratory route yielded low viremia titers with highly variable patterns of onset and duration (Table 4 ).
In the serological responses of monkeys aerogenically infected with Germiston virus, HI antibodies attained titers of 1:80 to 1:1,280 at 21 days. HI titers did not appear to be related to dose of virus inhaled. CF titers of samples taken 21 days after exposure by the respiratory route were suggestive of some degree of dose dependence (Table 5 ), but, because of the small number of samples involved, the differences in titers observed between doses were not statistically significant. The studies described herein establish that Germiston virus is infectious for rhesus and cynomolgus monkeys, but the disease, like that with Bunyamwera virus, appears extremely mild regardless of the dose or route of inoculation. In contrast, the disease described for man is considered acute and incapacitating (9) . The benign infections observed in the monkeys studied may have been a reflection of the species selected because, with several arboviruses, virulence is species-dependent. However, the relative ease with which rhesus monkeys were infected by aerosolized virus is noteworthy and serves to warn laboratory personnel of the potential hazards associated with this pathogen. The fact that Germiston virus is not of public health importance in endemic areas may be due to ineffective natural transmission of the virus rather than to the lack of virulence or infectivity for man.
The serological responses of monkeys to Germiston virus are discernable from those elicited by Bunyamwera virus. The detection of infections by serological techniques, even in the absence of detectable viremias, is of value for assessing crossprotection between these viruses (W. P. Allen and A. Schwartz, unpublished data).
LITERATURE CITED
